Physician profile
Deepti Kumar
NPI 1689795833
$3,896.62
in general payments reported to CMS, 2019-2025
17 companies · $418 in 2025
The $418 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,062 · 2020: $357 · 2021: $168 · 2022: $380 · 2023: $732 · 2024: $779 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,929.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $815.34 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $612.48 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $575.84 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $392.84 | 2019-2024 | |
| Amgen INC. | $303.94 | 2019-2025 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $260.95 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals Lp | $238.16 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $178.11 | 2019-2022 | |
| Lantheus Medical Imaging, INC. | $113.37 | 2019-2023 | Definity |
| Sanofi-Aventis U.S. LLC | $101.81 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $89.77 | 2024 | Arcalyst |
| Medtronic Vascular, INC. | $62.37 | 2019-2020 | |
| Amarin Pharma, INC. | $57.70 | 2020 | |
| Solventum Corporation | $32.56 | 2024 | Prevena, Activ.A.C. |
| Vifor Pharma, INC. | $23.61 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $20.17 | 2019 | |
| Scpharmaceuticals INC. | $17.60 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepti Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.